• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杂环在乳腺癌治疗中的应用:吡唑衍生物的使用。

Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives.

机构信息

Laboratorio de Organocatálisis Asimétrica, Departamento de Química Orgánica. Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza. C/Pedro Cerbuna 12, E-50009 Zaragoza, Spain.

出版信息

Curr Med Chem. 2023;30(10):1145-1174. doi: 10.2174/0929867329666220829091830.

DOI:10.2174/0929867329666220829091830
PMID:36043746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11475274/
Abstract

Among the aromatic heterocycle rings, pyrazole -a five-membered ring with two adjacent nitrogen atoms in its structure has been postulated as a potent candidate in the pharmacological context. This moiety is an interesting therapeutic target covering a broad spectrum of biological activities due to its presence in many natural substances. Hence, the potential of the pyrazole derivatives as antitumor agents has been explored in many investigations, showing promising results in some cases. In this sense, breast cancer, which is already the leading cause of cancer mortality in women in some countries, has been the topic selected for this review, which covers a range of different research from the earliest studies published in 2003 to the most recent ones in 2021.

摘要

在芳香杂环环中,吡唑 - 结构中具有两个相邻氮原子的五元环,已被假定为药理学背景下的有力候选物。由于其存在于许多天然物质中,该部分是一个有趣的治疗靶标,涵盖了广泛的生物活性。因此,吡唑衍生物作为抗肿瘤剂的潜力已在许多研究中得到探索,在某些情况下显示出有希望的结果。在这个意义上,乳腺癌,在某些国家已经是女性癌症死亡率的主要原因,已经成为本综述的主题,涵盖了从 2003 年发表的最早研究到 2021 年的最新研究的一系列不同的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/302c8b7eaa8f/CMC-30-1145_F22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/67c4588dd793/CMC-30-1145_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/f2f1d2cf42a5/CMC-30-1145_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/036975605ea8/CMC-30-1145_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/d23e948daae4/CMC-30-1145_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/a82999f13a16/CMC-30-1145_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/2dc3053c0e63/CMC-30-1145_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/5c56d9fe7d22/CMC-30-1145_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/fc63f8561cc1/CMC-30-1145_F8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/1b200aa8be81/CMC-30-1145_F9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/3bfc2d12ed0a/CMC-30-1145_F10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/683510472cfa/CMC-30-1145_F11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/532562b25538/CMC-30-1145_F12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/774eb075834f/CMC-30-1145_F13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/acb3ba7f3825/CMC-30-1145_F14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/d17d2f29ef72/CMC-30-1145_F15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/420a5fc51612/CMC-30-1145_F16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/8206928ee3c3/CMC-30-1145_F17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/ad9b0c4974ea/CMC-30-1145_F18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/e863d9565313/CMC-30-1145_F19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/4644d744bd67/CMC-30-1145_F20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/426e86644ea9/CMC-30-1145_F21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/302c8b7eaa8f/CMC-30-1145_F22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/67c4588dd793/CMC-30-1145_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/f2f1d2cf42a5/CMC-30-1145_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/036975605ea8/CMC-30-1145_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/d23e948daae4/CMC-30-1145_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/a82999f13a16/CMC-30-1145_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/2dc3053c0e63/CMC-30-1145_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/5c56d9fe7d22/CMC-30-1145_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/fc63f8561cc1/CMC-30-1145_F8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/1b200aa8be81/CMC-30-1145_F9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/3bfc2d12ed0a/CMC-30-1145_F10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/683510472cfa/CMC-30-1145_F11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/532562b25538/CMC-30-1145_F12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/774eb075834f/CMC-30-1145_F13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/acb3ba7f3825/CMC-30-1145_F14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/d17d2f29ef72/CMC-30-1145_F15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/420a5fc51612/CMC-30-1145_F16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/8206928ee3c3/CMC-30-1145_F17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/ad9b0c4974ea/CMC-30-1145_F18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/e863d9565313/CMC-30-1145_F19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/4644d744bd67/CMC-30-1145_F20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/426e86644ea9/CMC-30-1145_F21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6db/11475274/302c8b7eaa8f/CMC-30-1145_F22.jpg

相似文献

1
Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives.杂环在乳腺癌治疗中的应用:吡唑衍生物的使用。
Curr Med Chem. 2023;30(10):1145-1174. doi: 10.2174/0929867329666220829091830.
2
Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.吡唑衍生物作为一种抗癌剂在不同细胞系中的最新发展概述。
Bioorg Chem. 2020 Apr;97:103470. doi: 10.1016/j.bioorg.2019.103470. Epub 2019 Dec 14.
3
Recently reported biological activities of pyrazole compounds.吡唑化合物最近报道的生物活性。
Bioorg Med Chem. 2017 Nov 1;25(21):5891-5903. doi: 10.1016/j.bmc.2017.09.035. Epub 2017 Sep 23.
4
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers.具有体内抗癌治疗潜力的吡唑杂合体的现状。
Eur J Med Chem. 2023 Sep 5;257:115495. doi: 10.1016/j.ejmech.2023.115495. Epub 2023 May 16.
5
Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.新型噻唑取代双吡唑啉肟衍生物的设计、合成及通过选择性诱导癌细胞凋亡和 ROS 产生的抗肿瘤活性的生物评价。
Med Chem. 2019;15(7):743-754. doi: 10.2174/1573406414666180827112724.
6
Synthesis of Chromone-Related Pyrazole Compounds.合成色酮相关吡唑类化合物。
Molecules. 2017 Oct 5;22(10):1665. doi: 10.3390/molecules22101665.
7
Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle.含与五元杂环稠合的吡唑的生物活性体系的最新进展。
Eur J Med Chem. 2015 Jun 5;97:732-46. doi: 10.1016/j.ejmech.2014.12.023. Epub 2014 Dec 18.
8
Current scenario of pyrazole hybrids with anti-breast cancer therapeutic applications.具有抗乳腺癌治疗应用的吡唑杂合体的现状。
Arch Pharm (Weinheim). 2024 Oct;357(10):e2400344. doi: 10.1002/ardp.202400344. Epub 2024 Jun 29.
9
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review.基于吡唑骨架的神经保护剂的最新进展:综述。
CNS Neurol Disord Drug Targets. 2022;21(10):940-951. doi: 10.2174/1871527320666210602152308.
10
Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.吡唑衍生物作为抗癌剂的研究进展。
Int J Mol Sci. 2023 Aug 12;24(16):12724. doi: 10.3390/ijms241612724.

引用本文的文献

1
Bioactive Fused Pyrazoles Inspired by the Adaptability of 5-Aminopyrazole Derivatives: Recent Review.受5-氨基吡唑衍生物适应性启发的生物活性稠合吡唑:近期综述
Molecules. 2025 Jan 17;30(2):366. doi: 10.3390/molecules30020366.
2
New Pyrazole/Pyrimidine-Based Scaffolds as Inhibitors of Heat Shock Protein 90 Endowed with Apoptotic Anti-Breast Cancer Activity.新型吡唑/嘧啶基支架作为热休克蛋白90抑制剂具有凋亡抗乳腺癌活性。
Pharmaceuticals (Basel). 2024 Sep 27;17(10):1284. doi: 10.3390/ph17101284.
3
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAF inhibitors.

本文引用的文献

1
Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.评价十年(2011-2020 年)中基于取代吡唑的激酶抑制剂:现状和未来展望。
Molecules. 2022 Jan 5;27(1):330. doi: 10.3390/molecules27010330.
2
-Heterocyclic Carbene Iron Complexes as Anticancer Agents: In Vitro and In Vivo Biological Studies.杂环卡宾铁配合物作为抗癌剂:体外和体内生物学研究。
Molecules. 2021 Sep 12;26(18):5535. doi: 10.3390/molecules26185535.
3
Synthesis of Novel Methyl 7-[(Hetero)arylamino]thieno[2,3-]pyrazine-6-carboxylates and Antitumor Activity Evaluation: Effects in Human Tumor Cells Growth, Cell Cycle Analysis, Apoptosis and Toxicity in Non-Tumor Cells.
合成具有凋亡抗增殖作用的新型4-吡唑基喹啉酮系列作为双靶点EGFR/BRAF抑制剂
RSC Med Chem. 2024 Jun 24;15(7):2538-2552. doi: 10.1039/d4md00230j. eCollection 2024 Jul 17.
4
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges.基于聚合物胶束的纳米凝胶作为乳腺癌治疗中的新兴药物传递系统:前景与挑战。
Curr Drug Targets. 2024;25(10):649-669. doi: 10.2174/0113894501294136240610061328.
5
Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy.用于 siRNA 递送和基因治疗的智能物理化学触发的壳聚糖基纳米凝胶:聚焦癌症治疗的新兴策略和范例
Curr Med Chem. 2024 Jun 5. doi: 10.2174/0109298673286052240426044945.
6
Stimuli-sensitive Chitosan-based Nanosystems-immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma.基于刺激响应性壳聚糖的纳米系统固定化核酸用于乳腺癌和肝癌的基因治疗。
Curr Top Med Chem. 2024;24(17):1464-1489. doi: 10.2174/0115680266293173240506054439.
7
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.高度功能化吡唑腙和酰胺的结构-活性关系研究作为抗增殖和抗氧化剂。
Int J Mol Sci. 2024 Apr 23;25(9):4607. doi: 10.3390/ijms25094607.
8
pH/ Temperature/ Redox and Light-responsive Polymersome Structure and Application in Cancer Therapy: Smart Drug Delivery and Targeted Drug Release.pH/温度/氧化还原与光响应性聚合物囊泡的结构及其在癌症治疗中的应用:智能药物递送与靶向药物释放
Curr Med Chem. 2025;32(22):4456-4480. doi: 10.2174/0109298673303351240507113603.
9
Quantum Dots in Cancer Theranostics: A Thorough Review of Recent Advancements in Bioimaging, Tracking, and Therapy Across Various Cancer Types.量子点在癌症诊疗中的应用:对不同癌症类型生物成像、追踪及治疗方面最新进展的全面综述
Curr Pharm Biotechnol. 2025;26(8):1120-1142. doi: 10.2174/0113892010294163240407153842.
10
Pyrazole: an emerging privileged scaffold in drug discovery.吡唑:药物发现中新兴的优势骨架。
Future Med Chem. 2023 Nov;15(21):2011-2023. doi: 10.4155/fmc-2023-0207. Epub 2023 Nov 7.
新型甲硫基 7-[(杂)芳基氨基]噻吩并[2,3-]吡嗪-6-羧酸酯的合成及其抗肿瘤活性评价:对人肿瘤细胞生长、细胞周期分析、细胞凋亡和非肿瘤细胞毒性的影响。
Molecules. 2021 Aug 10;26(16):4823. doi: 10.3390/molecules26164823.
4
Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468.吡唑衍生物通过 MDA-MB-468 三阴性乳腺癌细胞中 ROS 的生成诱导细胞凋亡。
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):2079-2087. doi: 10.31557/APJCP.2021.22.7.2079.
5
Novel ureido-dihydropyridine scaffolds as theranostic agents.新型脲基二氢吡啶支架作为治疗诊断一体化试剂。
Bioorg Chem. 2020 Dec;105:104364. doi: 10.1016/j.bioorg.2020.104364. Epub 2020 Oct 10.
6
Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.含氮杂环作为抗癌剂:概述。
Anticancer Agents Med Chem. 2020;20(18):2150-2168. doi: 10.2174/1871520620666200705214917.
7
Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.斑马鱼癌症模型——在非哺乳动物脊椎动物中模拟人类癌症的新见解。
Genes (Basel). 2019 Nov 15;10(11):935. doi: 10.3390/genes10110935.
8
Advanced technological tools to study multidrug resistance in cancer.用于研究癌症多药耐药性的先进技术工具。
Drug Resist Updat. 2020 Jan;48:100658. doi: 10.1016/j.drup.2019.100658. Epub 2019 Oct 17.
9
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.